Sources Catanese, Lisa
Grauslund, J., Abou Taha, A., Dehghani Molander, L., Kawasaki, R., Mller, S., Hjlund, K., & Stokholm, L., Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes, International Journal of Retina and Vitreous , accepted for publication
Weight Watchers is currently offering FDA-approved medications such as Ozempic, Trulicity, Victoza, Wegovy, Zepbound, Mounjaro, Saxenda, and Metformin instead of compounded semaglutide through the WW clinic
Extended outages of 12 to 24 hours are more concerning
Supporting Evidence: Studies have shown fasting insulin is a more sensitive early marker of metabolic dysfunction compared to glucose alone (Reaven, 1988)